15/05/2026
๐ฐ ๐๐๐ฐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐ซ๐๐ฅ๐๐๐ฌ๐๐ ๐ญ๐จ๐๐๐ฒ ๐๐ก๐๐ฅ๐ฅ๐๐ง๐ ๐๐ฌ ๐ญ๐ก๐ ๐ง๐๐ซ๐ซ๐๐ญ๐ข๐ฏ๐ ๐จ๐ง ๐๐๐ ๐ฌ๐๐ซ๐๐๐ง๐ข๐ง๐
Todayโs headlines suggest PSA screening โcauses more harm than goodโ โ but thatโs not the full picture!
A major new Cochrane review published today tells a different story:
๐ PSA testing is likely to reduce the risk of dying from prostate cancer
This is an important shift in the evidence.
โ
A PSA test is a simple blood test โ a first step, not a decision to treat
โ
Modern pathways (MRI, targeted assessment, active surveillance) mean men can be monitored safely and appropriately
โ
We now have better tools than ever to detect significant cancer early while avoiding unnecessary intervention
The real question is no longer whether to screen โ but how to do it better.
Men across the UK deserve clear, up-to-date information and access to smarter, risk-based screening approaches.
Prostate cancer screening could save thousands of lives a year and should be made an option for the vast majority of men, a landmark review has found.